Natural History of Untreated Nonsurgical Hepatocellular Carcinoma
暂无分享,去创建一个
John Wong | Sheung Tat Fan | B. C. Wong | S. Fan | C. Lo | J. Wong | Chung Mau Lo | Chi-leung Liu | Yuk Pang Yeung | Chi Leung Liu | Benjamin C Wong | Y. Yeung | B. Wong
[1] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[2] C. Lai,et al. Clinical features of hepatocellular carcinoma: Review of 211 patients in Hong Kong , 1981, Cancer.
[3] N. Nagasue,et al. The natural history of hepatocellular carcinoma. A study of 100 untreated cases , 1984, Cancer.
[4] H. Hasegawa,et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients , 1985, Cancer.
[5] L. Papoz,et al. Prognostic factors in patients with hepatocellular carcinoma attempts for the selection of patients with prolonged survival , 1987, Cancer.
[6] C. Lui,et al. Hepatocellular carcinoma in Hong Kong: clinical study on 340 cases. , 1990, Oncology.
[7] L. Bolondi,et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: A multivariate analysis of prognostic factors of tumor growth rate and patient survival , 1992, Hepatology.
[8] G. Dusheiko,et al. Management of hepatocellular carcinoma. , 1992, Journal of hepatology.
[9] S. Hadziyannis,et al. Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: A randomized, controlled trial , 1995, Hepatology.
[10] S. Pignata,et al. Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial , 1998, The Lancet.
[11] V. Sriuranpong,et al. Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients. , 1998, American journal of clinical oncology.
[12] J. Vauthey,et al. Pathological aspects of hepatocellular carcinoma: a critical review of prognostic factors. , 1998, Hepato-gastroenterology.
[13] E. Kouroumalis,et al. Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study , 1998, Gut.
[14] S. Fan,et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. , 1999, Annals of surgery.
[15] J. Bruix,et al. Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials , 1999, Hepatology.
[16] A. Moles,et al. Natural history of inoperable hepatocellular carcinoma: Estrogen receptors' status in the tumor is the strongest prognostic factor for survival , 2000, Hepatology.
[17] J. Bruix,et al. Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma , 2000, Hepatology.
[18] Bernardino,et al. Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma , 2000, Hepatology.
[19] ndrea,et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.
[20] P. Tangkijvanich,et al. Clinical Characteristics and Prognosis of Hepatocellular Carcinoma: Analysis Based on Serum Alpha-fetoprotein Levels , 2000, Journal of clinical gastroenterology.
[21] Bellia Mario,et al. Prospective validation of the CLIP score, a new prognostic system for cirrhotic patients with hepatocellular carcinoma (RE: Hepatology 2000, 32/3: 679-80) , 2000 .
[22] S. Fan,et al. Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study , 2000, American Journal of Gastroenterology.
[23] K. Shirabe,et al. [Prognostic factors in patients with hepatocellular carcinoma]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.
[24] T M Therneau,et al. A model to predict survival in patients with end‐stage liver disease , 2001, Hepatology.
[25] C. Balch,et al. AJCC Cancer Staging Manual. 6th ed , 2002 .
[26] Ramon Planas,et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial , 2002, The Lancet.
[27] H. El‐Serag. Hepatocellular carcinoma: an epidemiologic view. , 2002, Journal of clinical gastroenterology.
[28] S. Fan,et al. A randomized placebo‐controlled study of long‐acting octreotide for the treatment of advanced hepatocellular carcinoma , 2002, Hepatology.
[29] John Wong,et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma , 2002, Hepatology.
[30] L. Castagnetta,et al. Epidemiology, Risk Factors, and Natural History of Hepatocellular Carcinoma , 2002, Annals of the New York Academy of Sciences.
[31] D. Machin,et al. Simple clinical prognostic model for hepatocellular carcinoma in developing countries and its validation. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] M. Kudo,et al. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score) , 2003, Journal of Gastroenterology.
[33] J. Bruix,et al. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival , 2003, Hepatology.
[34] F. Farinati,et al. Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma , 1992, Digestive Diseases and Sciences.
[35] E. Xiao,et al. [Transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma]. , 2005, Zhonghua zhong liu za zhi [Chinese journal of oncology].
[36] D.,et al. Regression Models and Life-Tables , 2022 .